111In/225Actinium-DOTA-daratumumab

· City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 111In/225Actinium-DOTA-daratumumab, covering 2025-10-29 to 2025-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma [Phase 1]

See pricing